Patent 7129368 was granted and assigned to Sonus Pharmaceuticals Inc. on October, 2006 by the United States Patent and Trademark Office.
Platinum carboxylate anticancer compounds, pharmaceutical compositions that include the platinum carboxylate compounds, and methods for treating cellular proliferative diseases by administering the platinum carboxylate compounds.